University of New Mexico Clinical and Translational Science Center
University of New Mexico Clinical and Translational Science Center
批准号:
9085834
负责人:
Deborah Lynne Helitzer
金额:
$30.36万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-14 至 2020-03-31
关键词:
AddressAdvisory CommitteesAffectiveAreaAttentionCenter for Translational Science ActivitiesClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesDevelopment PlansDimensionsDisciplineEnsureEnvironmentEvaluationFacultyFundingGenerationsGoalsGood Clinical PracticeHealthIndividualInstitutionK-Series Research Career ProgramsLeadershipLinkMentorsMethodsMonitorNew MexicoOutcomePathway interactionsPersonality CharacterProcessRecording of previous eventsRecruitment ActivityRegulationReportingResearchResearch InfrastructureResearch PersonnelResearch TrainingResourcesRewardsRoleScienceScientistSelf PerceptionTime ManagementTrainingTraining ProgramsTraining and EducationTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWorkbasecareercareer developmentcohortcommercializationexperienceflexibilityimprovedinnovationmeetingsmembermultidisciplinarynext generationpatient orientedpeerpreferenceprogramsracial and ethnicskillssuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of the Mentored Career Development component (KL2) of our CTSC is to build the capacity
of our faculty to perform clinical and translational research (CTR), thereby addressing the significant health
problems of New Mexico, the region, and the nation. Our short-term objective is to enhance our KL2 program
by strengthening recruitment, augmenting individualized training, and improving mentoring to ensure that
scholars become independently funded by the end of their K-award period. A parallel KL2-like program, open
to additional faculty, with the same requirements, resources and training environment, has also been
developed with funds made available to our CTSC (not an institutional match). The success of our KL2
program demonstrates the important role of our CTSC in catalyzing CTR training, thereby strategically
increasing CTR capacity. The rationale for our approach is that by building on our already successful KL2
program, we will continue to develop the next generation of accomplished clinical and translational
researchers. We will accomplish this with the following specific aims: 1) Continue robust and sustained
leadership, administration, and institutional environment and commitment to the KL2 program; 2) Perform
national searches for KL2 scholars that include enhanced processes: a) to match recruits with optimal training
environments within our Signature Programs and departments, and b) to identify a racially/ethnically diverse
pool of candidates; 3) Develop, use, and monitor individual career development plans (IDP) that articulate
annual milestones and pathways for career development for five to ten years; 4) Enhance KL2 scholar
mentoring by requiring local-mentor training, adding mentors to the Multidisciplinary Advisory Committee, and
expanding the mentor team to include career mentors, peer mentors and, where appropriate, external mentors
who are nationally recognized experts in their fields, and; 5) Implement a comprehensive evaluation process,
including formative and summative components, for assessment of KL2 scholars, mentors, and the program.
The expected outcome of our program will be an enhanced capacity to conduct CTR on the most important
problems facing New Mexico, our region and the nation. We will attain this through heightened attention to the
factors that improve recruitment, training, mentoring and career development of a new cadre of young,
independently funded, and team science-oriented scientists. Such outcomes are expected to have an
important, long-term positive impact on our institution and the CTR workforce, resulting in a generation of
scientists trained in CTR; thereby promoting the nation’s priority to significantly accelerate the translation of
discovery into impact on health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of New Mexico Clinical and Translational Science Center
-
批准号:9127367
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2015
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Achieving a Critical Mass of Women Biomedical Faculty: Impact of 3 US Programs
-
批准号:8120910
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2009
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Achieving a Critical Mass of Women Biomedical Faculty: Impact of 3 US Programs
-
批准号:7713927
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2009
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Achieving a Critical Mass of Women Biomedical Faculty: Impact of 3 US Programs
-
批准号:8315913
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2009
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Achieving a Critical Mass of Women Biomedical Faculty: Impact of 3 US Programs
-
批准号:7933911
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2009
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Testing a video to improve provider-patient interaction
-
批准号:7126345
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2005
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Testing a video to improve provider-patient interaction
-
批准号:6959742
-
项目类别:
-
资助金额:$6.26万
-
财政年份:2005
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Computerized Risk Assessment in an Employee Population
-
批准号:7121254
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2004
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Computerized Risk Assessment in an Employee Population
-
批准号:6952866
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2004
-
负责人:Deborah Lynne Helitzer
-
依托单位:
Computerized Risk Assessment in an Employee Population
-
批准号:6913350
-
项目类别:
-
资助金额:$37.04万
-
财政年份:2004
-
负责人:Deborah Lynne Helitzer
-
依托单位:
海外基金